Our site uses cookies to make navigation as function as possible, including “third party” cookies and “profiling cookies” designed to tailor
on-line contents to suit the preferences expressed while surfing the internet. Should you wish to receive more information, or deny your
consent to some or all cookies, click here. If you proceed with browsing this website, you will be consenting to the use of all cookies.

FONDAZIONE MENARINI

A non-profit institution founded in 1976 to promote research...

GO TO SITE

MENARINI IN ASIA-PACIFIC

Find our companies

FEATURED

Latest News

November 04 2021

Menarini Receives FDA Orphan Drug Designation for SEL24/MEN1703, a first in class, dual PIM/FLT3 inhibitor for the Treatment of Acute Myeloid Leukemia

Read More
October 21 2021

Menarini Group and Radius Health Announce Positive Phase 3 Topline Results from the EMERALD Trial Evaluating Elacestrant in Breast Cancer

Read More
August 23 2021

Menarini Enters into an Exclusive Licensing Agreement with Daiichi Sankyo to Commercialise TARLIGE® in Singapore, Malaysia, and the Philippines

Read More
July 22 2021

Menarini Asia-Pacific strengthens Men’s Health portfolio in China with acquisition of Cialis® (Tadalafil) from Lilly

Read More
April 09 2021

Menarini Pills of Art Junior project launched, video clips made by the younger generations for children and teenagers

Read More